PURE BIOSCIENCE IN (PURE)

0.65
OTC Markets
Prev Close 0.65
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.55 / 1.36
Exchange OTC Markets
Shares Outstanding 68.06B
Market Cap 44.24M
Div & Yield N.A. (N.A)

Latest News

OTCQX And OTCQB Companies To Present At 2018 ROTH Conference

OTCQX And OTCQB Companies To Present At 2018 ROTH Conference

OTC Markets Group EVP Jason Paltrowitz to Speak on Panel on "Reg A+ Offerings"

PURE Bioscience Sets Fiscal 2018 Q2 Financial Results Conference Call

PURE Bioscience Sets Fiscal 2018 Q2 Financial Results Conference Call

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on March 14, 2018 the Company will file its Form 10-Q shortly after the close of...

PURE Bioscience Provides Update: Expanding Use Of PURE Control® Antimicrobial In Produce Processing; Expanding Use Of PURE® Hard Surface Disinfectant

PURE Bioscience Provides Update: Expanding Use Of PURE Control® Antimicrobial In Produce Processing; Expanding Use Of PURE® Hard Surface Disinfectant

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, provided an update on the expanded use of FDA approved PURE Control® antimicrobial for...

PURE Bioscience To Present At The 30th Annual ROTH Capital Partners Conference

PURE Bioscience To Present At The 30th Annual ROTH Capital Partners Conference

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today that the Company will present at the 30th Annual ROTH Capital Partners Conference on...

PURE Bioscience Receives Initial Orders From Leading Foodservice Distributor For PURE® Hard Surface Food Transport Sanitization Solution

PURE Bioscience Receives Initial Orders From Leading Foodservice Distributor For PURE® Hard Surface Food Transport Sanitization Solution

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today that a leading foodservice distributor has placed initial orders for PURE® Hard...

PURE Bioscience Reports Fiscal 2018 Q1 Financial Results

PURE Bioscience Reports Fiscal 2018 Q1 Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2017.

PURE Bioscience Sets Fiscal 2018 Q1 Financial Results Conference Call

PURE Bioscience Sets Fiscal 2018 Q1 Financial Results Conference Call

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on December 14, 2017 the Company will file its Form 10-Q shortly after the close...

PURE Bioscience To Present At The 10th Annual LD Micro Conference

PURE Bioscience To Present At The 10th Annual LD Micro Conference

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that Hank R.

PURE Bioscience Expands Board Of Directors With Appointment Of Elisabeth Hagen, M.D., Food Safety Consultant

PURE Bioscience Expands Board Of Directors With Appointment Of Elisabeth Hagen, M.D., Food Safety Consultant

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that it has named Elisabeth Hagen, M.

PURE Bioscience Reports Fiscal 2017 Year-End Financial Results

PURE Bioscience Reports Fiscal 2017 Year-End Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today reported financial results for the fiscal year ended July 31, 2017.

PURE Bioscience Announces Partnership With IGPS Logistics

PURE Bioscience Announces Partnership With IGPS Logistics

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today that it has signed an agreement with, and received an initial order from, iGPS...

PURE Bioscience Announces Superior In-Plant Poultry Parts Test Results With PURE Control® Antimicrobial

PURE Bioscience Announces Superior In-Plant Poultry Parts Test Results With PURE Control® Antimicrobial

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today that PURE Control® antimicrobial processing aid achieved strong results during...

PURE Bioscience Completes Successful Warrant Tender Offer And Raises $2.8 Million From Exercise Of Warrants

PURE Bioscience Completes Successful Warrant Tender Offer And Raises $2.8 Million From Exercise Of Warrants

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today that on October 10, 2017 it successfully completed a tender offer to amend and...

PURE Bioscience To Host Fiscal 2017 Year-End Financial Results Conference Call

PURE Bioscience To Host Fiscal 2017 Year-End Financial Results Conference Call

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today that on October 26, 2017 the Company will file its Form 10-K shortly after the close...

PURE Bioscience To Present At 2017 SeeThru Equity Investor Conference

PURE Bioscience To Present At 2017 SeeThru Equity Investor Conference

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that the Company will present at the 2017 SeeThru Equity Investor Conference at 11am...

PURE Control® Antimicrobial Listed As Safe And Suitable Ingredient In The USDA-FSIS Directive 7120.1 For Poultry Products

PURE Control® Antimicrobial Listed As Safe And Suitable Ingredient In The USDA-FSIS Directive 7120.1 For Poultry Products

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that PURE Control® antimicrobial is included in the newly updated list of Safe and...

PURE Bioscience To Present At 2017 Southern California Investor Conference

PURE Bioscience To Present At 2017 Southern California Investor Conference

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that the Company will present at the 2017 Southern California Investor Conference on...

PURE Bioscience Appoints Food Supply Chain Executive Janet Risi To Its Board Of Directors

PURE Bioscience Appoints Food Supply Chain Executive Janet Risi To Its Board Of Directors

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that it has named Janet Risi, President and CEO of Independent Purchasing Cooperative,...

PURE Bioscience Announces Co-Marketing And Supply Agreement With Roka Bioscience, Inc.

PURE Bioscience Announces Co-Marketing And Supply Agreement With Roka Bioscience, Inc.

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today announced that it has entered into a two-year nonexclusive supply agreement with Roka...

PURE Bioscience Reports 2017 Fiscal Third Quarter And Nine-Month Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today reported financial results for the fiscal third quarter and nine-month periods ended...

PURE Bioscience To Present At The 2017 Marcum Microcap Conference

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that the Company will present at the 2017 Marcum Microcap Conference on June...

PURE Bioscience Sets Q3 Results Conference Call To Review Progress Of SDC-Based Antimicrobial Food Safety Solutions Strategy

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today that the Company will publish fiscal Q3 financial results shortly after the market...

PURE Bioscience Receives Final FDA Acknowledgement Letter

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced that the Company has received final acknowledgement from the US Food and Drug Administration...

PURE Bioscience To Present At The B. Riley & Co. 18th Annual Investor Conference

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that the Company will present at the B.

PURE Bioscience Receives USDA Permission Letter And FDA FCN Acknowledgement Letter

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced that the Company has received two required key regulatory notifications on the Company's path...